8-K: Rayonier Advanced Materials Reports Improved Q1 2024 Results, Raises Free Cash Flow Guidance

Rayonier Advanced Materials exceeded expectations in the first quarter of 2024, driven by lower costs and improved demand for cellulose specialties, leading to increased free cash flow guidance for the year.

Summary

• Rayonier Advanced Materials (RYAM) reported a net loss of $2 million for the first quarter of 2024, which is a $4 million improvement compared to the prior year quarter.
• Adjusted EBITDA for the quarter was $52 million, a $1 million increase year-over-year.
• Net sales for the quarter were $388 million, down $79 million from the same period last year.
• The company's total debt stands at $779 million, with net secured debt at $721 million, resulting in a net secured debt ratio of 4.4 times.
• RYAM has increased its 2024 Adjusted Free Cash Flow guidance to $80 million to $100 million, while reaffirming its Adjusted EBITDA guidance of $180 million to $200 million.
• The company has suspended operations at its Temiscaming High Purity Cellulose plant, which is expected to improve free cash flow by $15 million to $20 million in 2024.
• The sale of refund rights for softwood lumber duties generated $39 million, with potential for additional proceeds.
• The bioethanol facility in Tartas, France, is now operational and is expected to contribute $3 million to $4 million of EBITDA in 2024, growing to $8 million to $10 million in 2025.

Sentiment

Score: 7

Explanation: The document presents a mixed picture with positive elements such as exceeding expectations, increased free cash flow guidance, and progress in biomaterials, but also includes negative aspects like a net loss and decreased sales. The strategic moves to reduce debt and focus on higher-value products are positive, but the slower-than-expected asset sales and one-time charges temper the overall sentiment.

Positives

• The company exceeded expectations for the first quarter of 2024.
• Adjusted EBITDA increased slightly year-over-year.
• Free cash flow guidance for 2024 has been increased.
• The suspension of the Temiscaming plant is expected to improve free cash flow.
• The bioethanol facility in Tartas is now operational and will contribute to EBITDA.
• The company is progressing with the sale of its Paperboard and High-Yield Pulp assets.
• The company has successfully refinanced its debt to provide operational flexibility.

Negatives

• Net sales decreased by $79 million compared to the prior year quarter.
• The company reported a net loss of $2 million for the quarter.
• Total sales volumes decreased by 17 percent, driven by declines in both cellulose specialties and commodity volumes.
• The company incurred $3 million in fees related to amending its 2027 Term Loan.
• The sale of the Temiscaming Paperboard and High-Yield Pulp facilities is progressing slower than expected.
• The company expects to incur one-time operating charges of approximately $30 million in 2024 related to the suspension of the Temiscaming plant.

Risks

• The company is exposed to macroeconomic and industry risks, including geopolitical conflicts and pandemics.
• The business is highly competitive and cyclical, which may lead to fluctuations in pricing and volume.
• Changes in the availability and price of raw materials and energy could negatively impact the company.
• The company is subject to risks associated with doing business outside of the United States, including foreign currency exchange fluctuations.
• A material disruption at any of the company's manufacturing plants could negatively impact operations.
• The company faces substantial asset risk, including potential impairment related to long-lived assets.
• The company has debt obligations that could materially affect its business and ability to meet obligations.
• The company may require additional financing in the future, which may not be available on favorable terms.

Future Outlook

The company expects to generate between $180 million and $200 million of Adjusted EBITDA in 2024 with $80 million to $100 million of Adjusted Free Cash Flow, including passive asset sales but excluding any operating asset sales. They anticipate a low single-digit percentage increase in average sales prices for cellulose specialties in 2024. The bioethanol facility in Tartas is expected to contribute $3 million to $4 million of EBITDA in 2024, growing to $8 million to $10 million beginning in 2025.

Management Comments

• First quarter results exceeded our expectations, driven by lower costs and improved demand for cellulose specialties.
• We delivered a solid $52 million in Adjusted EBITDA to maintain a net secured debt ratio of 4.4 times covenant EBITDA.
• We also increased capital expenditures to support growth in our Biomaterials strategy and increased net debt to boost inventory levels in preparation for Jesups annual outage.
• The solid first quarter, along with the start-up of the bioethanol facility in Tartas and the April completion of the planned maintenance outage in Jesup, keep us on track to deliver our full-year guidance of $180 to $200 million in Adjusted EBITDA.
• The suspension at Temiscaming will also reduce our exposure to the volatile commodity viscose market.
• We are focused on reducing debt with lower earnings volatility as we plan to refinance our senior secured notes prior to them becoming current in early 2025.

Industry Context

The announcement reflects a strategic shift towards higher-value cellulose specialties and biomaterials, aligning with industry trends towards sustainable and diversified product portfolios. The suspension of the Temiscaming plant indicates a move away from volatile commodity markets, which is a common strategy among companies seeking more stable revenue streams. The focus on debt reduction and refinancing is also a common theme in the current economic environment.

Comparison to Industry Standards

• Compared to competitors like Domtar and International Paper, RYAM's focus on high-purity cellulose and biomaterials represents a strategic differentiation.
• The adjusted EBITDA of $52 million is a positive result, but the net loss of $2 million highlights the challenges in the current market environment.
• The increase in free cash flow guidance to $80-$100 million is a positive sign, indicating improved operational efficiency and cost management.
• The net secured debt ratio of 4.4 times is within acceptable limits for the industry, but the company's focus on debt reduction is a prudent move.
• The bioethanol facility in Tartas is a significant investment in the growing biomaterials market, similar to other companies exploring renewable energy sources.
• The suspension of the Temiscaming plant is a strategic decision to reduce exposure to volatile commodity markets, a move also seen in other companies in the sector.

Stakeholder Impact

• Shareholders will be impacted by the improved free cash flow guidance and strategic moves to reduce debt and focus on higher-value products.
• Employees may be affected by the suspension of operations at the Temiscaming High Purity Cellulose plant, including potential severance and other employee costs.
• Customers will benefit from the company's focus on higher-value cellulose specialties and biomaterials.
• Suppliers may be impacted by changes in production volumes and the company's strategic shift.
• Creditors will be impacted by the company's focus on debt reduction and refinancing.

Next Steps

• The company will continue to progress the sale of its Paperboard and High-Yield Pulp assets at Temiscaming.
• The company will focus on reducing debt and refinancing its senior secured notes.
• The company will continue to invest in its biomaterials strategy, including the bioethanol facility in Tartas.
• The company will provide updates on the progress of its strategic initiatives throughout the year.
• The company will host a conference call on May 8, 2024, to discuss the results.

Key Dates

Keywords

cellulose specialties, EBITDA, free cash flow, biomaterials, Temiscaming, bioethanol, debt, high purity cellulose, paperboard, high-yield pulp